Randomized clinical trial of tissue equivalent bolus prescription in postmastectomy radiotherapy stratified by skin involvement status

Whelan, 2000, Does loco regional radiation therapy improve survival in breast cancer? A meta-analysis, J Clin Oncol, 18, 1220, 10.1200/JCO.2000.18.6.1220 Clarke, 2005, Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials, Lancet, 366, 2087, 10.1016/S0140-6736(05)67887-7 McGale, 2014, Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials, Lancet, 383, 2127, 10.1016/S0140-6736(14)60488-8 Kaidar-Person, 2021, Tricks and tips for target volume definition and delineation in breast cancer: lessons learned from ESTRO breast courses, Radiother Oncol, 162, 185, 10.1016/j.radonc.2021.07.015 Darby, 2013, Risk of ischemic heart disease in women after radiotherapy for breast cancer, N Engl J Med, 368, 987, 10.1056/NEJMoa1209825 Erven, 2012, Changes in pulmonary function up to 10 years after locoregional breast irradiation, Int J Radiat Oncol Biol Phys, 82, 701, 10.1016/j.ijrobp.2010.12.058 Prochazka, 2005, Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: case-only design, J Clin Oncol, 23, 7467, 10.1200/JCO.2005.01.7335 Boice, 1992, Cancer in the contralateral breast after radiotherapy for breast cancer, N Engl J Med, 326, 781, 10.1056/NEJM199203193261201 Ginzton, 1957, The Stanford medical linear accelerator. I. Design and development, Stanford Med Bull, 15, 123 Velkley, 1975, Build-up region of mega-voltage photon radiation sources, Med Phys, 2, 14, 10.1118/1.594158 Tieu, 2011, The effect of adjuvant postmastectomy radiotherapy bolus technique on local recurrence, Int J Radiat Oncol Biol Phys, 81, e165, 10.1016/j.ijrobp.2011.01.002 Yap, 2018, Outcomes in patients treated with post-mastectomy chest wall radiotherapy without the routine use of bolus, Clin Oncol (R Coll Radiol), 30, 427, 10.1016/j.clon.2018.03.005 Turner, 2016, Technique and outcome of post-mastectomy adjuvant chest wall radiotherapy – the role of tissue-equivalent bolus in reducing risk of local recurrence, Br J Radiol, 89, 20160060, 10.1259/bjr.20160060 Nichol, 2021, The effect of bolus on local control for patients treated with mastectomy and radiation therapy, Int J Radiat Oncol Biol Phys, 110, 1360, 10.1016/j.ijrobp.2021.01.019 Abel, 2017, Local failure and acute radiodermatological toxicity in patients undergoing radiation therapy with and without postmastectomy chest wall bolus: is bolus ever necessary?, Pract Radiat Oncol, 7, 167, 10.1016/j.prro.2016.10.018 Corrigan KL, Mainwaring W, Miller AB, et al. Exclusion of man from randomized phase III breast cancer clinical trials. Oncologist 2020;25(6):e990-992. (PMID: 32272505). Zeidan, 2018, Postmastectomy radiation therapy in women with T1–T2 tumors and 1 to 3 positive lympho nodes: analysis of the breast international group 02–98 trial, Int J Radiat Oncol Biol Phys, 101, 316, 10.1016/j.ijrobp.2018.01.105 Fossaluza, 2009, Sequential allocation to balance prognostic factors in a psychiatric clinical trial, Clinics (Sao Paulo), 64, 511, 10.1590/S1807-59322009000600005 World Health Organization, 1995, Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee, World Health Organ Tech Rep Ser, 854, 1 Xie, 2021, Risk factors related to acute radiation dermatitis in breast cancer patients after radiotherapy: a systematic review and meta-analysis, Front Oncol, 11, 10.3389/fonc.2021.738851 Cox, 1995, Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC), Int J Radiat Oncol Biol Phys, 31, 1341, 10.1016/0360-3016(95)00060-C Rogatko, 2004, Patient characteristics compete with dose as predictors of acute treatment toxicity in early phase clinical trials, Clin Cancer Res, 10, 5645, 10.1158/1078-0432.CCR-03-0535 Razaee, 2021, On the properties of the toxicity index and its statistical efficiency, Stat Med, 40, 1535, 10.1002/sim.8858 Gresham, 2020, Evaluating treatment tolerability in cancer clinical trials using the toxicity index, J Natl Cancer Inst, 112, 1266, 10.1093/jnci/djaa028 Fay, 2018, Confidence intervals of the Mann-Whitney parameter that are compatible with the Wilcoxon-Mann-Whitney test, Stat Med, 37, 3991, 10.1002/sim.7890 De Neve, 2017, A Mann-Whitney type effect measure of interaction for factorial designs, Commun Stat-Theory Methods, 46, 11243, 10.1080/03610926.2016.1263739 De Neve, 2015, A regression framework for rank tests based on the probabilistinc index model, J Am Stat Assoc, 110, 1276, 10.1080/01621459.2015.1016226 De Neve, 2013, Goodness-of-fit methods for probabilistic index models, Commun Stat-Theory Methods, 42, 1193, 10.1080/03610926.2012.695851 Thas, 2012, Probabilistic index models, J R Stat Soc Ser B (Stat Methodol), 74, 623, 10.1111/j.1467-9868.2011.01020.x Meys J, De Neve J, Sabbe N, Amorim GGA. pim: Fit Probabilistic Index Models. 2020; R package version 2.0.2. https://CRAN.R-project.org/package=pim. R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2020. Available at: https://www.R-project.org/; last accessed on 07/10/2022. Pignol, 2015, Prospective evaluation of severe skin toxicity and pain during postmastectomy radiation therapy, Int J Radiat Oncol Biol Phys, 91, 157, 10.1016/j.ijrobp.2014.09.022 Saunders, 1968, Central axis depth doses for a constant source-tumour distance, Br J Radiol, 41, 464, 10.1259/0007-1285-41-486-464 Hughes, 1959, Measurements of superficial absorbed dose with 2 MV x rays used at glancing angles, Br J Radiol, 32, 255, 10.1259/0007-1285-32-376-255 Bush, 1962, The measurement of build-up on curved surfaces exposed to Co60 and Cs137 beams, Am J Roentgenol Radium Ther Nucl Med, 87, 89 Jackson, 1971, Surface effects of high-energy X rays at oblique incidence, Br J Radiol, 44, 109, 10.1259/0007-1285-44-518-109 Barker, 1976, Inflammatory carcinoma of the breast, Radiology, 121, 173, 10.1148/121.1.173 Thoms, 1989, Multimodal treatment for inflammatory breast cancer, Int J Radiat Oncol Biol Phys, 17, 739, 10.1016/0360-3016(89)90060-6 Soong, 2004, Post-mastectomy radiotherapy after immediate autologous breast reconstruction in primary treatment of breast cancers, Clin Oncol (R Coll Radiol), 16, 283, 10.1016/j.clon.2004.01.007 Uematsu, 1993, Long-term results of post-operative radiation therapy following mastectomy with or without chemotherapy in stage I-III breast cancer, Int J Radiat Oncol Biol Phys, 25, 765, 10.1016/0360-3016(93)90303-D Kaidar-Person, 2021, A Delphi study and international consensus recommendations: the use of bolus in the setting of postmastectomy radiation therapy for early breast cancer, Radiother Oncol, 164, 115, 10.1016/j.radonc.2021.09.012 Dahn, 2021, The use of bolus in postmastetomy radiation therapy for breast cancer: a systematic review, Crit Rev Oncol Hematol, 163, 10.1016/j.critrevonc.2021.103391 Vu, 2007, Variability in radiation oncologists’ opinion on the indication of a bolus in post-mastectomy radiotherapy: an international survey, Clin Oncol (R Coll Radiol), 19, 115, 10.1016/j.clon.2006.10.004 Thomas, 2014, Radiation practice patterns among United States radiation oncologists for postmastectomy breast reconstruction and oncoplastic breast reduction, Pract Radiat Oncol, 4, 466, 10.1016/j.prro.2014.04.002 Taghian, 2004, J Clin Oncol, 22, 4247, 10.1200/JCO.2004.01.042 Haviland, 2013, The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials, Lancet Oncol, 14, 1086, 10.1016/S1470-2045(13)70386-3 Brunt, 2020, Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial, Lancet, 395, 1613, 10.1016/S0140-6736(20)30932-6